A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; Expanding the use of Vi polysaccharide vaccine in Southeast China: A cluster-randomized trial
Open Access
- 18 May 2005
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 5 (1) , 49
- https://doi.org/10.1186/1471-2458-5-49
Abstract
Background: One of the goals of this study was to learn the coverage, safety and logistics of a mass vaccination campaign against typhoid fever in children and adults using locally produced typhoid Vi polysaccharide (PS) and group A meningococcal PS vaccines in southern China. Methods: The vaccination campaign targeted 118,588 persons in Hechi, Guangxi Province, aged between 5 to 60 years, in 2003. The study area was divided into 107 geographic clusters, which were randomly allocated to receive one of the single-dose parenteral vaccines. All aspects regarding vaccination logistics, feasibility and safety were documented and systematically recorded. Results of the logistics, feasibility and safety are reported. Results: The campaign lasted 5 weeks and the overall vaccination coverage was 78%. On average, the 30 vaccine teams gave immunizations on 23 days. Vaccine rates were higher in those aged ≤ 15 years (90%) than in adolescents and young adults (70%). Planned mop-up activities increased the coverage by 17%. The overall vaccine wastage was 11%. The cold chain was maintained and documented. 66 individuals reported of adverse events out of all vaccinees, where fever (21%), malaise (19%) and local redness (19%) were the major symptoms; no life-threatening event occurred. Three needle-sharp events were reported. Conclusion: The mass immunization proved feasible and safe, and vaccine coverage was high. Emphasis should be placed on: injection safety measures, community involvement and incorporation of mop-up strategies into any vaccination campaign. School-based and all-age Vi mass immunizations programs are potentially important public health strategies for prevention of typhoid fever in high-risk populations in southern China.Keywords
This publication has 13 references indexed in Scilit:
- A multi‐country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and designTropical Medicine & International Health, 2005
- Policymakers’ views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in AsiaVaccine, 2004
- The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.2004
- Field evaluation of vaccine safetyVaccine, 2004
- Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.2003
- An Outbreak of Typhoid Fever, Xing‐An County, People's Republic of China, 1999: Estimation of the Field Effectiveness of Vi Polysaccharide Typhoid VaccineThe Journal of Infectious Diseases, 2001
- The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old ChildrenNew England Journal of Medicine, 2001
- Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.2001
- PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVERThe Lancet, 1987
- Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella TyphiNew England Journal of Medicine, 1987